109 related articles for article (PubMed ID: 8792698)
21. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D
Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of Helicobacter pylori infection in patients with reflux esophagitis. A case-control study].
Carmona-Sánchez R; Navarro-Cano G
Rev Gastroenterol Mex; 2003; 68(1):23-8. PubMed ID: 12940095
[TBL] [Abstract][Full Text] [Related]
23. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding.
Lee JM; Breslin NP; Fallon C; O'Morain CA
Am J Gastroenterol; 2000 May; 95(5):1166-70. PubMed ID: 10811322
[TBL] [Abstract][Full Text] [Related]
24. Is Helicobacter pylori eradication indicated in cirrhotic patients with peptic ulcer disease?
Villalan R; Maroju NK; Kate V; Ananthakrishnan N
Trop Gastroenterol; 2006; 27(4):166-8. PubMed ID: 17542294
[TBL] [Abstract][Full Text] [Related]
25. [Endoscopic approach in HIV infected-patients with upper gastrointestinal symptoms].
Olmos MA; Fanín A; Araya V; Piskorz E; Quesada EC; Magnanini F; Concetti H; Perez H; Cahn P
Acta Gastroenterol Latinoam; 2004; 34(3):120-6. PubMed ID: 15742926
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of peptic ulcer disease in cirrhotic patients: role of Helicobacter pylori infection.
Calvet X; Navarro M; Gil M; Lafont A; Sanfeliu I; Brullet E; Campo R; Dalmau B; Rivero E; Mas P
Am J Gastroenterol; 1998 Dec; 93(12):2501-7. PubMed ID: 9860415
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Gisbert JP; Legido J; García-Sanz I; Pajares JM
Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
[TBL] [Abstract][Full Text] [Related]
29. Histological and clinical predictive value of determination of tissue CagA status by PCR in Helicobacter pylori infected patients; results of the large population based study in western Turkey.
Saruç M; Demir MA; Küçükmetin N; Kandiloglu AR; Akarca US; Yüceyar H
Hepatogastroenterology; 2002; 49(45):878-81. PubMed ID: 12064012
[TBL] [Abstract][Full Text] [Related]
30. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya.
Bakka AS; El-Gariani AB; AbouGhrara FM; Salih BA
Saudi Med J; 2002 Oct; 23(10):1261-5. PubMed ID: 12436134
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori density and cagA status in cirrhotic patients: a case-control study.
Zullo A; Sanchez-Mete L; Hassan C; Diana F; Festuccia F; Attili AF; Morini S
J Gastroenterol Hepatol; 2004 Oct; 19(10):1174-8. PubMed ID: 15377296
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
[TBL] [Abstract][Full Text] [Related]
33. The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.
García-Díaz E; Castro-Fernández M; Romero-Gómez M; Vargas-Romero J
Rev Esp Enferm Dig; 2002 Dec; 94(12):725-36. PubMed ID: 12733331
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of Helicobacter pylori and endoscopic findings in HIV seropositive patients with upper gastrointestinal tract symptoms at Kenyatta National Hospital, Nairobi.
AliMohamed F; Lule GN; Nyong'o A; Bwayo J; Rana FS
East Afr Med J; 2002 May; 79(5):226-31. PubMed ID: 12638804
[TBL] [Abstract][Full Text] [Related]
35. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
[TBL] [Abstract][Full Text] [Related]
36. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
Schaeverbeke T; Broutet N; Zerbib F; Combe B; Bertin P; Lamouliatte H; Perié F; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 2005 Dec; 100(12):2637-43. PubMed ID: 16393213
[TBL] [Abstract][Full Text] [Related]
37. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.
Mönkemüller KE; Call SA; Lazenby AJ; Wilcox CM
Am J Gastroenterol; 2000 Feb; 95(2):457-62. PubMed ID: 10685750
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
[TBL] [Abstract][Full Text] [Related]
39. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
40. Dyspepsia in HIV-infected patients under highly active antiretroviral therapy.
Werneck-Silva AL; Prado IB
J Gastroenterol Hepatol; 2007 Nov; 22(11):1712-6. PubMed ID: 17559368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
